202 related articles for article (PubMed ID: 37421505)
1. Lack of surgical resection is associated with increased early mortality in hematological patients complicated with rhino-orbital-cerebral mucormycosis.
Chen X; Xiao J; Wang X; Lu X; An J; Zhao J; Wei J; Wei J; He S; Tian W
Ann Hematol; 2023 Oct; 102(10):2933-2942. PubMed ID: 37421505
[TBL] [Abstract][Full Text] [Related]
2. Managing mucormycosis in diabetic patients: A case report with critical review of the literature.
Beiglboeck FM; Theofilou NE; Fuchs MD; Wiesli MG; Leiggener C; Igelbrink S; Augello M
Oral Dis; 2022 Apr; 28(3):568-576. PubMed ID: 33583133
[TBL] [Abstract][Full Text] [Related]
3. Mucormycosis.
Reid G; Lynch JP; Fishbein MC; Clark NM
Semin Respir Crit Care Med; 2020 Feb; 41(1):99-114. PubMed ID: 32000287
[TBL] [Abstract][Full Text] [Related]
4. Rhino-orbito-cerebral mucormycosis: five cases.
Toumi A; Larbi Ammari F; Loussaief C; Hadhri R; Ben Brahim H; Harrathi K; Ben Romdhane F; Koubaa J; Chakroun M
Med Mal Infect; 2012 Dec; 42(12):591-8. PubMed ID: 23116703
[TBL] [Abstract][Full Text] [Related]
5. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
[TBL] [Abstract][Full Text] [Related]
6. Mortality and its determinants after an outbreak of post COVID-19 associated rhino-orbito-cerebral mucormycosis in Central India.
Nagarkar NM; Sahu V; Arora R; Pathak M; Shambharkar MS; Naveen P
Int Ophthalmol; 2023 Jul; 43(7):2363-2370. PubMed ID: 36645635
[TBL] [Abstract][Full Text] [Related]
7. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
8. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
Nair AG; Dave TV
Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
[TBL] [Abstract][Full Text] [Related]
9. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study.
Cag Y; Erdem H; Gunduz M; Komur S; Ankarali H; Ural S; Tasbakan M; Tattevin P; Tombak A; Ozturk-Engin D; Tartar AS; Batirel A; Tekin R; Duygu F; Caskurlu H; Kurtaran B; Durdu B; Haciseyitoglu D; Rello J;
Eur J Intern Med; 2022 Jun; 100():56-61. PubMed ID: 35304041
[TBL] [Abstract][Full Text] [Related]
10. [Mucormycosis in patients with hematological diseases: seven cases reports and literature review].
Qi Y; Zhao MF; Deng Q; Geng L
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):943-947. PubMed ID: 31856445
[No Abstract] [Full Text] [Related]
11. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient.
Fairley C; Sullivan TJ; Bartley P; Allworth T; Lewandowski R
Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895
[TBL] [Abstract][Full Text] [Related]
12. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
[TBL] [Abstract][Full Text] [Related]
13. The potential for rapid antigen testing for mucormycosis in the context of COVID-19.
Thornton CR
Expert Rev Mol Diagn; 2024 Mar; 24(3):161-167. PubMed ID: 37405409
[TBL] [Abstract][Full Text] [Related]
14. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.
Liang KP; Tleyjeh IM; Wilson WR; Roberts GD; Temesgen Z
J Clin Microbiol; 2006 Mar; 44(3):892-8. PubMed ID: 16517873
[TBL] [Abstract][Full Text] [Related]
15. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q
BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and outcome of invasive fungal sinusitis in children with hematological malignancies.
Eissa S; Khedr R; Romeih M; Halaby L; Elanany M; Madney Y
Med Mycol; 2022 Apr; 60(4):. PubMed ID: 35134980
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
Bala K; Chander J; Handa U; Punia RS; Attri AK
Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
[TBL] [Abstract][Full Text] [Related]
19. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Riley TT; Muzny CA; Swiatlo E; Legendre DP
Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
[TBL] [Abstract][Full Text] [Related]
20. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]